Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

21 June 2018

Policy

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Position paper on Best Procurement Practices

28 April 2018

Policy

IGBA position on identification of biological, including biosimilar medicines (2018 update of facts & figures)

20 April 2018

Policy

Life Science Industry Coalition Position paper

14 December 2017

Policy

Joint statement – European health community calls on the EU and UK to prioritise patients as crunch Article 50 decision approaches

7 December 2017

Policy

Today a group of organisations representing patients, healthcare professionals and […]

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy